Hyd-Based Drug Maker Granules India Limited Receives Fortune Award:- For being in the elite list of 25 greatest value creators in the Fortune India Next 500 universe, Hyderabad-based drug maker Granules India Limited has received Fortune award.
The company also features in the list at 60th rank. It was ranked at 111 position in 2016 in the list of the Next 500 Companies.
Fortune India recently organized a function on 21 July, 2017, to present the awards to top 25 greatest value creator companies. The award was presented by Amitabh Kant, CEO Niti Ayog, Government of India and Mr D.N. Mukerjea, Editor, Fortune India.
On this occasion Krishna Prasad, Chairman and Managing Director, Granules India Limited said “It is indeed a proud moment for all of us at Granules to be honored and recognized by Fortune India. The award is the testimony to our continuous effort to create value to all our stakeholders and society at large”.
A growing pharmaceutical manufacturing company with world class facilities is Granules India Limited. The company is committed to operational excellence, quality and customer service. For quality conscious customers in the regulated and less-regulated markets of the world, the Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) are produced by the company.
With unique value, extensive product range, and proactive solutions, Granules India Limited supports customers. Through offices in India, U.S., and U.K, the company’s global presence extends to over 250 customers in 60 countries.
Granules India Limited offers all three components of the pharmaceutical value chain which gives the customers flexibility and choice.
SUPRAJA
